Page last updated: 2024-12-08

aspergillomarasmine a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID197028
CHEMBL ID4087144
SCHEMBL ID17616108
MeSH IDM0190517

Synonyms (15)

Synonym
brn 2422056
(r-(r*,r*))-n-(2-((2-amino-2-carboxyethyl)amino)-2-carboxyethyl)-l-aspartic acid
aspergillomarasmine a
l-aspartic acid, n-(2-((2-amino-2-carboxyethyl)amino)-2-carboxyethyl)-, (r-(r*,r*))-
toxin c (pyrenophora teres)
3484-65-9
k4f9bjq6eg ,
aspartic acid, n-(2-((2-amino-2-carboxyethyl)amino)-2-carboxyethyl)-, d-
unii-k4f9bjq6eg
n-((2r)-2-(((2r)-2-amino-2-carboxyethyl)amino)-2-carboxyethyl)-l-aspartic acid
SCHEMBL17616108
Q18205331
CHEMBL4087144
n-{2-[(2-amino-2-carboxyethyl)amino]-2-carboxyethyl}aspartic acid
DTXSID60956312
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID1462678Inhibition of NDM1 in Klebsiella pneumoniae ATCC BAA-2146 assessed as rescue concentration needed to fully regain activity of meropenem at clinical breakpoint (2.5 uM) by cell-based synergy screening assay2017Bioorganic & medicinal chemistry, 10-01, Volume: 25, Issue:19
Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance.
AID1462681Inhibition of NDM1 in Klebsiella pneumoniae ATCC BAA-2146 assessed as potentiation of meropenem-induced microbial growth inhibition by measuring compound MIC by cell-based synergy screening assay2017Bioorganic & medicinal chemistry, 10-01, Volume: 25, Issue:19
Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance.
AID1462677Inhibition of NDM1 (unknown origin) pre-incubated for 10 mins before nitrocefin substrate addition2017Bioorganic & medicinal chemistry, 10-01, Volume: 25, Issue:19
Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance.
AID1604439Inhibition of NDM1 (unknown origin) using nitrocefin as substrate incubated for 10 mins by UV spectra analysis2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
β-Lactamase Inhibitors To Restore the Efficacy of Antibiotics against Superbugs.
AID1462684Inhibition of NDM1 in Klebsiella pneumoniae ATCC BAA-2146 assessed as potentiation of meropenem-induced microbial growth inhibition by measuring meropenem MIC by cell-based synergy screening assay (Rvb (meropenem MIC alone) = 8 microg/ml)2017Bioorganic & medicinal chemistry, 10-01, Volume: 25, Issue:19
Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance.
AID1759804Inhibition of NDM-1 (unknown origin) expressed in Escherichia coli BW25113deltabamBdeltatolC mutant using nitrocefin as substrate by colorimetric analysis2021European journal of medicinal chemistry, Jul-05, Volume: 219Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D).
AID1462679Inhibition of NDM1 in Klebsiella pneumoniae ATCC BAA-2146 assessed as potentiation of meropenem-induced microbial growth inhibition by cell-based synergy screening assay2017Bioorganic & medicinal chemistry, 10-01, Volume: 25, Issue:19
Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance.
AID1578802Potentiation of meropenem-induced antibacterial activity against Klebsiella pneumoniae N11-2218 harboring NDM1 infected in CD1 mouse assessed as mouse survival at 30 mg/kg, sc administered 30 mins post infection and measured 5 days post infection (Rvb = 02019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Antibiotic Adjuvants: Make Antibiotics Great Again!
AID1578823Inhibition of beta-lactamase NDM-1 in Klebsiella pneumoniae N11-2218 assessed as potentiation of meropenem-induced antibacterial activity by measuring meropenem MIC at 8 ug/ml (Rvb =32 ug/ml)2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Antibiotic Adjuvants: Make Antibiotics Great Again!
AID1462682Growth inhibition of Klebsiella pneumoniae ATCC BAA-21462017Bioorganic & medicinal chemistry, 10-01, Volume: 25, Issue:19
Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (11.76)18.2507
2000's0 (0.00)29.6817
2010's10 (58.82)24.3611
2020's5 (29.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.13 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.38 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (17.65%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (82.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]